CLINICAL TRIALS PROFILE FOR BMS-963272

Clinical Trials for BMS-963272

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT02327273 ↗	Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects	Completed	Bristol-Myers Squibb	Phase 1	The purpose of this study is to evaluate the safety profile, tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) following single and multiple oral doses of BMS-963272 in healthy subjects.
NCT04116632 ↗	A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults	Completed	Bristol-Myers Squibb	Phase 1	This study will assess the safety and tolerability of multiple doses of BMS-963272 in obese but otherwise healthy participants.
NCT04124003 ↗	A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin	Completed	Bristol-Myers Squibb	Phase 1	Phase 1 study that assesses the effect of BMS-963272 on exposure of rosuvastatin in healthy participants

Clinical Trial Conditions for BMS-963272

Condition Name

Condition Name
Intervention	Trials
Healthy	1
Healthy Participants	1
Nonalcoholic Fatty Liver Disease	1

Condition MeSH

Condition MeSH
Intervention	Trials
Non-alcoholic Fatty Liver Disease	1
Liver Diseases	1
Fatty Liver	1

Clinical Trial Locations for BMS-963272

Trials by Country

Trials by Country
Location	Trials
United States	13

Trials by US State

Trials by US State
Location	Trials
Texas	2
Washington	1
Tennessee	1
Missouri	1
Mississippi	1

Clinical Trial Progress for BMS-963272

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 1	4

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	3
Recruiting	1

Clinical Trial Sponsors for BMS-963272

Sponsor Name

Sponsor Name
Sponsor	Trials
Bristol-Myers Squibb	4

Sponsor Type

Sponsor Type
Sponsor	Trials
Industry	4